Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2027

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Blood sample Truculture

"blood sample added to the standard blood test at visit Inclusion and Month 6. This project will use the TruCulture® Whole Blood Stimulation System to assess the Whole Blood Oxylipin Response (WBOR).~WBOR is the ability of patients to produce oxylipins in response to an immune stimulus. One tube is conditioned with LPS stimulant and a control tube is conditioned with no stimulant (Null)."

Trial Locations (3)

42055

CHU Saint Etienne, Saint-Etienne

63000

CHU Clermont-Ferrand, Clermont-Ferrand

75014

Hopital Cochin, APHP, Paris

All Listed Sponsors
collaborator

Unité de Nutrition Humaine, INRAE, Centre Auvergne-Rhône Alpes

UNKNOWN

collaborator

Immunology department, CHU Clermont-Ferrand

UNKNOWN

collaborator

University of Southampton, Southampton, United Kingdom

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT06880146 - Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter